Security Devices International, Inc. logo

Security Devices International, Inc. (SDEV)

Market Closed
3 Jun, 20:00
OTCQB OTCQB
$
1. 1600
+0.01
+0.87%
$
30.64M Market Cap
- P/E Ratio
4% Div Yield
70,704 Volume
- Eps
$ 1.15
Previous Close
Add Transaction
Day Range
1.1 1.1665
Year Range
1.08 99.75
Want to track SDEV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SDEV closed today higher at $1.16, an increase of 0.87% from yesterday's close, completing a monthly decrease of -24.68% or -$0.38. Over the past 12 months, SDEV stock lost -15.94%.
SDEV is not paying dividends to its shareholders.
Security Devices International, Inc. has completed 4 stock splits, with the recent split occurring on Feb 23, 2026.
The company's stock is traded on one exchange.

SDEV Chart

People also search for

Theralase Technologies Inc.
$ 0.17
+5.63%
Cell Source Inc.
$ 0.77
-3.75%
Telescope Innovations Corp.
$ 0.61
+12.19%
Vivos Inc.
$ 0.06
-0.41%
Inhibitor Therapeutics Inc.
$ 0.08
-1.18%

Security Devices International, Inc. (SDEV) FAQ

What is the stock price today?

The current price is $1.1600.

On which exchange is it traded?

Security Devices International, Inc. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is SDEV.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4%.

What is its market cap?

As of today, the market cap is 30.64M.

Has Security Devices International, Inc. ever had a stock split?

Security Devices International, Inc. had 4 splits and the recent split was on Feb 23, 2026.

Security Devices International, Inc. Profile

Pharmaceuticals Industry
Healthcare Sector
Michael Kazley CEO
OTCQB Exchange
66987P508 CUSIP
US Country
4 Employees
30 Sep 2025 Last Dividend
23 Feb 2026 Last Split
- IPO Date

Overview

Stablecoin Development Corp. is a pioneering company dedicated to the advancement and commercialization of scientifically-developed and clinically-validated products in the eye care and skin care sectors. Established on January 19, 2000, and headquartered in Emeryville, California, the company has positioned itself as a leader in innovation, utilizing cutting-edge scientific research to create products that enhance health and well-being. The company's commitment to quality and efficacy is reflected in its portfolio, which includes a range of solutions designed to address various healthcare needs in both the dermatological and ophthalmic fields.

Products and Services

  • Avenova

    Avenova is an advanced topical solution specifically formulated for eyelid hygiene. This product is clinically proven to effectively cleanse and refresh the eyelids while eliminating bacteria and debris. Designed for individuals suffering from conditions like blepharitis, Avenova provides a soothing experience that helps promote overall eye health.

  • NeutroPhase

    NeutroPhase is a unique, scientifically-formulated cleanser that targets skin conditions requiring a gentle yet effective treatment. Utilizing a proprietary technology, it aids in the removal of impurities and supports the healing of skin, making it an ideal choice for patients with acne, eczema, or other dermatological concerns. Its biocompatible formula ensures safety and effectiveness for a variety of skin types.

  • DERMAdoctor

    DERMAdoctor offers a wide range of skincare products developed to address specific skin concerns such as dryness, pigmentation, and aging. Each product is backed by clinical research, ensuring that consumers receive solutions tailored to their individual needs. This brand emphasizes efficacy and quality, delivering remarkable results to users looking for effective dermatological care.

Contact Information

Address: 2000 Powell Street
Phone: 1 510 899-8800